The biotechnology company posted revenue of $23.5 million in the period, beating Street forecasts. Four analysts surveyed by Zacks expected $18.3 ...
News
- NGM Biopharmaceuticals: 3Q Earnings Snapshot
- Axcella Reports Third Quarter 2020 Financial Results and Provides Business Update
BUSINESS WIRE)-- Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases and ...
- India announces $35 billion economic stimulus package
... said the package includes 9 billion rupees ($121 million) for development of a COVID-19 vaccine by the government's biotechnology department.
- COVID-19 Impact On Global Acrylamides Market,Top key players @ Kowa Chemicals ...
... Impact On Global Acrylamides Market,Top key players @ Kowa Chemicals, AMERICANBIO, AMRESCO, Cube Biotech, ... 1604 W San Antonio,.
- Impact of COVID-19 On Global Adiponectin Testing Market,Top key players @ Eagle Biosciences ...
Top key players @ Eagle Biosciences, Boster Biological Technology, Merck, Thermo fisher Scientific, Bio-Rad, LabCorp, ... 1604 W San Antonio,.